These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8233444)

  • 61. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans.
    Nishizawa H; Handayaningsih AE; Iguchi G; Cho Y; Takahashi M; Yamamoto M; Suda K; Kasahara K; Hakuno F; Yamanouchi K; Nishihara M; Seino S; Takahashi S; Takahashi Y
    Growth Horm IGF Res; 2012 Apr; 22(2):64-8. PubMed ID: 22370764
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly.
    Misaki T; Maciel RM; Tramontano D; Moses AC; Lombardi A; Ingbar SH
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1227-32. PubMed ID: 3372685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adiponectin and Cardiac Hypertrophy in Acromegaly.
    Gurbulak S; Akin F; Yerlikaya E; Yaylali GF; Topsakal S; Tanriverdi H; Akdag B; Kaptanoglu B
    Adv Clin Exp Med; 2016; 25(3):449-55. PubMed ID: 27629732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical assessment of bone formation and resorption in acromegaly.
    Ezzat S; Melmed S; Endres D; Eyre DR; Singer FR
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of growth factors in degenerative joint disorders.
    Moskowitz RW; Boja B; Denko CW
    J Rheumatol Suppl; 1991 Feb; 27():147-8. PubMed ID: 2027117
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acromegaly or chronic renal failure: a diagnostic dilemma.
    Wong NA; Ahlquist JA; Camacho-Hübner C; Goodwin CJ; Dattani M; Marshall NJ; Wass JA
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):221-6. PubMed ID: 9135706
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of acromegaly by measurement of 24-hourly urinary growth hormone excretion.
    Pholséna M; Le Bouc Y; Rousseau E; Christol R; Birman P; Périn L; Girard F
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):9-14. PubMed ID: 8447199
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of insulin-like growth factor-I in diagnosis and management of acromegaly.
    Clemmons DR
    Endocr Pract; 2004; 10(4):362-71. PubMed ID: 15760781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity.
    Main KM; Lindholm J; Vandeweghe M; Skakkebaek NE
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):409-13. PubMed ID: 8279221
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurements.
    Katsumata N
    Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):209-215. PubMed ID: 28516748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Growth-hormone-binding protein in patients with acromegaly.
    Amit T; Ish-Shalom S; Glaser B; Youdim MB; Hochberg Z
    Horm Res; 1992; 37(6):205-11. PubMed ID: 1292973
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome.
    Yamada S; Aiba T; Takada K; Ozawa Y; Shimizu T; Sawano S; Shishiba Y; Sano T
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):291-8. PubMed ID: 8949566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Normal values of insulin-like growth factor I and their clinical utility in adults.
    Strasburger CJ; Bidlingmaier M; Wu Z; Morrison KM
    Horm Res; 2001; 55 Suppl 2():100-5. PubMed ID: 11684886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery.
    Okada Y; Morimoto I; Ejima K; Yoshida K; Kashimura M; Fujihira T; Eto S
    Endocr J; 1997 Feb; 44(1):117-20. PubMed ID: 9152623
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.
    Varewijck AJ; Lamberts SW; van der Lely AJ; Neggers SJ; Hofland LJ; Janssen JA
    J Clin Endocrinol Metab; 2015 Jan; 100(1):309-16. PubMed ID: 25337924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment.
    Brabant G
    Eur J Endocrinol; 2003 Apr; 148 Suppl 2():S15-20. PubMed ID: 12670296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Feline acromegaly: a review of the syndrome.
    Hurty CA; Flatland B
    J Am Anim Hosp Assoc; 2005; 41(5):292-7. PubMed ID: 16141180
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.
    Kanakis GA; Chrisoulidou A; Bargiota A; Efstathiadou ZA; Papanastasiou L; Theodoropoulou A; Tigas SK; Vassiliadi DA; Tsagarakis S; Alevizaki M
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):681-688. PubMed ID: 27292418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.